Table 2. Range of AROCs of Asian and White DRSs for Diabetes, Dysglycemia, and Metabolic Syndrome Among 451 Participants in Rural Kerala, India.
Outcome Variable | Range of AROCs of Asian DRSs | Range of AROCs of White DRSsa |
---|---|---|
Diabetesb | 0.776–0.802 | 0.716–0.828 |
Dysglycemiac | 0.771–0.801 | 0.713–0.804 |
Metabolic syndromed | 0.793–0.874 | 0.651–0.911 |
Abbreviations: AROCs, areas under the receiver operating characteristic curves; DRSs, diabetes risk scores.
Excluding Rotterdam Prediction Model 1 (7).
Fasting plasma glucose ≥126 mg/dL or on antidiabetes medication, or both.
Impaired fasting glucose (fasting plasma glucose 110–125 mg/dL and not on antidiabetes medication) or diabetes (fasting plasma glucose ≥126 mg/dL, or on antidiabetes medication, or both).
Three or more of the following: raised triglycerides (≥150 mg/dL, or treatment of this lipid abnormality), reduced HDL cholesterol (<40 mg/dL in men and <50 mg/dL in women, or treatment of this lipid abnormality), raised blood pressure (systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥85 mm Hg or treatment of previously diagnosed hypertension), or raised fasting plasma glucose (≥100 mg/dL or previously diagnosed type 2 diabetes).